Skip to main content
ADTX
NASDAQ Life Sciences

Aditxt, Inc. Finalizes 1-for-8 Reverse Stock Split to Regain Nasdaq Compliance

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$0.485
Mkt Cap
$265.512K
52W Low
$0.43
52W High
$1,977.482
52W Position info
13% above low
Off High info
100% below high
Rel. Volume
Market data snapshot near publication time

ADTX is trading near its 52-week low of $0.43 (13% above the low).

Summary

Aditxt, Inc. will effect a 1-for-8 reverse stock split on March 6, 2026, with trading on a split-adjusted basis beginning March 9, 2026, primarily to meet Nasdaq's minimum bid price requirement.


Key Events · Corporate Governance and Compliance · ADTX

  • Reverse Stock Split Finalized

    The Board of Directors approved a 1-for-8 reverse stock split, effective March 6, 2026, with split-adjusted trading commencing on the Nasdaq Capital Market on March 9, 2026.

  • Nasdaq Compliance Objective

    The reverse stock split is primarily intended to bring the company into compliance with Nasdaq's minimum bid price requirement, as previously authorized by stockholders on February 13, 2026.

  • Share Structure Adjustment

    Every eight shares of common stock will be combined into one, with fractional shares rounded up. Outstanding stock options and warrants will be proportionately adjusted. Approximately 517,856 shares will be issued and outstanding post-split.


Analysis · ADTX · Life Sciences

Aditxt, Inc. has finalized a 1-for-8 reverse stock split, a critical move primarily aimed at regaining compliance with Nasdaq's minimum bid price requirement. While necessary to maintain its listing, reverse splits are generally viewed negatively by the market as they often signal underlying financial distress or a history of poor stock performance. The low post-split share count of approximately 517,856 shares indicates continued volatility risk for this micro-cap company. Investors should monitor the stock's performance post-split and the company's ability to sustain the minimum bid price.

At the time of this filing, ADTX was trading at $0.49 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $265.5K. The 52-week trading range was $0.43 to $1,977.48. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

ADTX - Latest Insights

ADTX
Jul 17, 2026, 12:06 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.0025
Real-time Price: $0.0031 info
Change: +$0.0006 (+24%) info
Market Cap: $3.094M info
ADTX
Jun 24, 2026, 11:36 AM EDT
Filing Type: 8-K
Importance Score:
10
Price at Filing: $0.050599
Real-time Price: $0.0031 info
Change: -$0.047499 (-94%) info
Market Cap: $3.094M info
ADTX
Jun 24, 2026, 3:13 AM EDT
Source: Wiseek News
Importance Score:
9
Price at Filing: $0.0406
Real-time Price: $0.0031 info
Change: -$0.0375 (-92%) info
Market Cap: $3.094M info
ADTX
Jun 23, 2026, 4:23 PM EDT
Source: Wiseek News
Importance Score:
9
Price at Filing: $0.0443
Real-time Price: $0.0031 info
Change: -$0.0412 (-93%) info
Market Cap: $3.094M info
ADTX
Jun 23, 2026, 4:22 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.0445
Real-time Price: $0.0031 info
Change: -$0.0414 (-93%) info
Market Cap: $3.094M info